Building Biotech to Last [Entire Talk]
Culture
The keys to future success must be established at the beginning of a platform biotech company.
Duration
46:16
Part of Series
Entrepreneurial Thought Leaders
Season
Season 18
Episode
7
Dr. Trevor Martin is the CEO and co-founder of Mammoth Biosciences, which addresses challenges across healthcare, agriculture, environmental monitoring, biodefense, and more through discovery of novel CRISPR systems to power the next generation of CRISPR-based synthetic biology products. Ursheet Parikh is a partner at the venture capital firm Mayfield, where he co-leads the Human and Planetary Health investment practice, which includes an investment in Mammoth. In this conversation with Stanford adjunct lecturer Ravi Belani, Martin and Parikh share their advice for building a platform biotech company with staying power.
Video clips from: Building Biotech to Last [Entire Talk]
- 46:16The keys to future success must be established at the beginning of a platform biotech company.
- 3:43Platform biotech companies must have a built-to-last mindset from the start.
- 3:07Platform biotech companies should establish a culture of strategic planning to manage risk.
- 2:31Values are at the core of ethical biotech companies.
- 3:00Biotech platform companies should think strategically about the markets they target.